🔎 Trials Near Me

Beranda › Penyakit Crohn › Ohio › Cleveland

Uji klinis Penyakit Crohn di Cleveland, OH

19 studi untuk Penyakit Crohn mencari peserta di lokasi sekitar Cleveland (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Menerima pesertaFase 3
  • Great Lakes Gastroenterology Research, LLC ( Site 5016), Mentor · 22 mi jauhnya
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06430801

Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease

Menerima pesertaSukarelawan sehat diterima
  • University Hospitals Cleveland Medical Center, Cleveland
  • UH Minoff Health Center, Chagrin Falls · 17 mi jauhnya
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07852273

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Menerima pesertaFase 4
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi jauhnya
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06581328

Non-nutritive Sweeteners in Inflammatory Bowel Disease

Menerima pesertaSukarelawan sehat diterima
  • University Hospitals Cleveland Medical Center, Cleveland
  • UH Minoff Health Center, Chagrin Falls · 17 mi jauhnya
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07769437

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Menerima pesertaFase 2
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi jauhnya
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06233461

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Menerima pesertaFase 3
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07499232

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Menerima pesertaFase 3
  • University Hospitals Cleveland Medical Center-Site Number: 8400073, Cleveland
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07184931

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Menerima pesertaFase 3
  • Cleveland Clinic - Cleveland /ID# 256453, Cleveland
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT05995353

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Menerima pesertaFase 4
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi jauhnya
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06045754

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

Menerima pesertaFase 3
  • Great Lakes Gastroenterology Research, LLC, Mentor · 22 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07577843

Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD

Menerima peserta
  • Cleveland Clinic, Cleveland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07680283

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Menerima pesertaFase 3
  • UH Cleveland Medical Center /ID# 262188, Cleveland
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 24 Jun 2026 · NCT06332534

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Menerima pesertaFase 3
  • University Children's Clinic, Cleveland
  • Cleveland Clinic, Cleveland
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT06405087

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Menerima pesertaFase 4
  • UH/Rainbow Babies and Children's Hospital, Cleveland
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT05781152

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Menerima pesertaFase 3
  • University Hospitals Cleveland Medical Center - 11100 Euclid Ave, Cleveland
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 7 Mei 2026 · NCT05442567

Precise Infliximab Exposure and Pharmacodynamic Control

Menerima pesertaFase 2/3
  • Cleveland Clinic Children's Hospital, Cleveland
Usia 6 hingga 22 · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT05660746

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Menerima pesertaFase 3
  • University Hospitals Cleveland Medical Center, Cleveland
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT04779320

Treatment of Moderate to Severe Refractory Crohn's Disease

Menerima pesertaFase 1/2
  • Cleveland Clinic, Cleveland
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 10 Des 2025 · NCT06721962

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy

Menerima pesertaStudi observasional
  • Cleveland Clinic Foundation, Cleveland
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Nov 2025 · NCT06670638

Uji klinis Penyakit Crohn di kota lain

Studi lain di Cleveland

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.